On ECHEMI
Home > Drugs > Alogliptin benzoate Registered Holders
Alogliptin benzoate structure

Alogliptin benzoate structure

Alogliptin benzoate

Alogliptin benzoate(SYR 322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.IC50 value: <10 nMTarget: DPP4Alogliptin is an orally administered, anti-diabetic drug in the DPP-4 inhibitor class. A randomized clinical trial reporting in 2011 aimed to determine the efficacy and safety of alogliptin versus placebo and voglibose among newly diagnosed Type 2 diabetes patients in Japan. The main outcome indicated

Find 31 Related Holders

Zhe JIANG HUA HAI Pharmaceutical Co., Ltd.
China China

API Registration Country

API Inactive
  • Founded in:

    2001-02-28
  • Country:

    China China
  • Address:

    Xunqiao, Linhai City, Zhejiang Province
  • Tax NO.:

    91330000147968817N
  • Registered Funds:

    1.491754938 yuan
  • Website:

  • Email:

Recommended Suppliers of Alogliptin benzoate
View 103 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.